The first-ever clinical practice guideline for the drug treatment of obesity offers a new tool for health practitioners looking to the latest pharmacotherapy strategies as a means of treating patients with obesity. The Obesity Society says the guideline supplements the TOS/AHA/ACC Obesity Treatment Guidelines to fill a gap in treatment.